AWARDED PROJECTS

Noa Therapeutics

Overview

Noa Therapeutics (Toronto) is a biotech company working to create better treatments for the millions of people struggling with inflammatory illnesses like eczema, ulcerative colitis and inflammatory bowel disease.

What they’re doing: Noa is in the advanced development phase of a non-steroidal medication that targets inflammatory barrier diseases and are preparing to conduct a clinical trial on humans.

How will this be used in the real world? Over 200 million people around the world suffer from eczema, making it the leading cause of skin disease. Current treatments temporarily address the symptoms but Noa is developing medications that can provide lasting relief.